Clinical Trial Update: Umbilical Cord Derived Mesenchymal Stem Cells for Treatment-induced Myelosuppression in Hematologic Malignancies [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating umbilical cord–derived mesenchymal stem cells for treatment-induced myelosuppression in hematologic malignancies; current st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Bleeding
• Hematologic Neoplasms
• Infections
• Neutropenia
• Thrombocytopenia

Drugs mentioned

• Umbilical cord-derived mesenchymal stem cells (mesenchymal stem cells)

Snippet

Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Conditions: Hematologic Neoplasms, Neutropenia | Phase 1, Phase 2 | Status: UNKNOWN